Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 700
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +21%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 251–300 of 494 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05179486	Molecular Epidemiology of Biliary Tree Cancers	recruiting	—	1,500	M.D. Anderson Cancer CenterOTHER	1	Apr 17, 2026	clinicaltrials
NCT05967182	A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma	recruiting	Phase 2	24	M.D. Anderson Cancer CenterOTHER	1	Apr 16, 2026	clinicaltrials